Bull Of The Day: Repligen
October 19, 2015 at 14:55 PM EDT
Repligen (RGEN - Snapshot Report) is a $900 million "biotech" company, without the drugs. Repligen supplies R&D and commercial scale recombinant Protein A and affinity chromatography resins to world-class partners and customers.
